广发纳斯达克生物科技人民币(001092)

动态评分: 2.62分

投资组合

报告日期 名称 比例
2023-12-31 Castle Biosciences Inc 0.05%
2023-12-31 Enliven Therapeutics Inc 0.05%
2023-12-31 和黄医药(US ADR) 0.05%
2023-12-31 Marinus Pharmaceuticals Inc 0.05%
2023-12-31 诺瓦瓦克斯医药 0.05%
2023-12-31 宠物IQ 0.05%
2023-12-31 Phathom Pharmaceuticals Inc 0.05%
2023-12-31 Replimune Group Inc 0.05%
2023-12-31 ARS Pharmaceuticals Inc 0.05%
2023-12-31 Theravance Biopharma Inc 0.05%
2023-12-31 Tourmaline Bio Inc 0.05%
2023-12-31 Wave Life Sciences Ltd 0.05%
2023-12-31 Arbutus Biopharma Corp 0.04%
2023-12-31 AC Immune SA 0.04%
2023-12-31 Cullinan Oncology Inc 0.04%
2023-12-31 Centessa Pharmaceuticals Plc ADR 0.04%
2023-12-31 Fulcrum Therapeutics Inc 0.04%
2023-12-31 Harrow Health Inc 0.04%
2023-12-31 iTeos Therapeutics Inc 0.04%
2023-12-31 Janux Therapeutics Inc 0.04%

投资模拟

公告&资料